IMA and MIT > Close collaboration, strengthened for innovation

Italy, Ozzano dell’Emilia – Designer and manufacturer of automatic machines for the processing and packaging of pharmaceuticals, cosmetics, food, tea and coffee

 

 

Alberto Vacchi, IMA’s Chairman and CEO, met on 18th july 2017 at the Ozzano dell’Emilia’s Service Centre the Director of the Deshpande Center of the MIT of Boston, Leon Sandler.

Alberto Vacchi (on the left), IMA's Chairman and CEO, with Leon Sandler, Director of the Deshpande Center of the MIT of Boston.

Alberto Vacchi (on the left), IMA’s Chairman and CEO, with Leon Sandler, Director of the Deshpande Center of the MIT of Boston.

The Deshpande Center, foundation of MIT

IMA S.p.A.’s entry into the Deshpande Center, a Boston MIT foundation for innovation, strengthens a long-standing collaboration on specific topics. Personally, I’m increasingly convinced that true innovation, that is appreciated by end users because it meets their growth needs, is crucial to a company like IMA, which focuses exclusively on the quality and reliability of the products and services it offers. We will continue to invest in innovation, even with an M&A strategy aimed at acquiring functional skills for our businesses” – commented IMA’s Chairman.

The corporate video of IMA: innovation and automation first.

 

Info about IMA:

Established in 1961, IMA is world leader in the design and manufacture of automatic machines for the processing and packaging of pharmaceuticals, cosmetics, food, tea and coffee.

The Group has more than 5,200 employees, more than 2,600 of whom overseas, and can count on 39 production plants in Italy, Germany, France, Switzerland, Spain, the United Kingdom, the United States, India, Malaysia, China and Argentina.

IMA has an extensive sales network comprising 29 branches which provide sales and service in Italy, France, Switzerland, the United Kingdom, Germany, Austria, Spain, Poland, Israel, Russia, the United States, India, China, Malaysia, Thailand and Brazil, representative offices in Central and East European countries and over 50 agencies covering a total of about 80 countries.

IMA S.p.A. has been listed on the Milan Stock Exchange since 1995 and in 2001 joined the STAR segment. The following manufacturing companies are part of the IMA Group: Benhil GmbH, Co.ma.di.s. S.p.A., Corazza S.p.A., Delta Systems & Automation Inc., Erca S.A., Erca-Formseal Ibérica S.A., Fillshape S.r.l., Gasti Verpackungsmaschinen GmbH, Gima S.p.A., Gima TT S.p.A., G.S. Coating Technologies S.r.l., Hamba Filltec GmbH & Co. KG, Hassia Packaging Pvt. Ltd., Hassia Verpackungsmaschinen GmbH, Ilapak International SA, Ilapak Italia S.p.A., Ilapak (Beijing) Packaging Machinery Co. Ltd., IMA Automation Malaysia Sdn. Bhd., IMA Automation USA Inc., IMA Life North America Inc., IMA Life (Beijing) Pharmaceutical Systems Co. Ltd., IMA MAI S.A., IMA Medtech Switzerland S.A., IMA North America Inc., IMA-PG India Pvt. Ltd., IMA Swiftpack Ltd., Mapster S.r.l., PharmaSiena Service S.r.l., Revisioni Industriali S.r.l., Shanghai Tianyan Pharmaceutical Machinery Co. Ltd., Teknoweb Converting S.r.l., Telerobot S.p.A.

More info about IMA: IMA

 

Previous > Harting - The sensor actuator boxes to save time and money
Next Vitronic > Set the standard in quality inspections of welded seams

You might also like

News

Schaeffler > Actuators for future mobility

        Threee innovative and particoularly systems at the NAIAS Electromechanical and electrohydraulic systems are being used more and more frequently in drive trains and chassis for functions

News

Jenoptic > Fast and precise 3D metal cutting laser machine at EuroBlech

      Jenoptik presents fast and precise 3D metal cutting laser machine at EuroBLECH Jenoptik’s Automotive division is presenting its laser machine series for 3D metal cutting JENOPTIK-VOTAN® BIM

Automation / Energy

Schunk > Intelligent gripping systems for smart production

      SCHUNK presents intelligent gripping systems for smart production “Over the coming five years, industrial gripping will be wholly reinvented,” Dr. Markus Klaiber highlights with respect to the